Stay updated on Satralizumab in Generalized Myasthenia Gravis Clinical Trial
Sign up to get notified when there's something new on the Satralizumab in Generalized Myasthenia Gravis Clinical Trial page.

Latest updates to the Satralizumab in Generalized Myasthenia Gravis Clinical Trial page
- Check5 days agoNo Change Detected
- Check13 days agoChange DetectedAdded a note that publications are automatically filled from PubMed and updated the revision tag from v3.2.0 to v3.3.2.SummaryDifference0.1%

- Check20 days agoChange DetectedRemoved the banner about the government funding lapse and NIH operating status; this administrative change does not affect study details or trial data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check41 days agoChange DetectedExternal information links to MedlinePlus Genetics, DailyMed, PubMed, and NIH/NLM pages were removed from the Study Details page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check63 days agoChange Detected- Added a government-operations notice about potential delays and current status, plus links for updates. - Updated version to v3.2.0. - Removed the previous v3.1.0 reference.SummaryDifference2%

- Check70 days agoChange DetectedMajor update: page now shows Revision: v3.1.0 and removes several drug-safety topics; indicates a content reorganization rather than addition of new substantive material.SummaryDifference0.2%

- Check84 days agoChange DetectedRevision: v3.0.2 added; previous v3.0.1 removed, and the 'Back to Top' element was deleted.SummaryDifference0.1%

Stay in the know with updates to Satralizumab in Generalized Myasthenia Gravis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Satralizumab in Generalized Myasthenia Gravis Clinical Trial page.